These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21876346)

  • 1. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Ozols E; Young MJ; Bennett BL; Friedman GC; Tesch GH
    Am J Nephrol; 2011; 34(4):337-46. PubMed ID: 21876346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
    Lehfeld LS; Silveira LA; Ghini B; Lopes de Faria JB
    Kidney Blood Press Res; 2004; 27(2):114-20. PubMed ID: 15051931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR; Doyle AE; Cooper ME
    Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus.
    Biswas SK; Lopes de Faria JB
    Am J Nephrol; 2006; 26(5):415-22. PubMed ID: 16960441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.
    Awad AS; Huang L; Ye H; Duong ET; Bolton WK; Linden J; Okusa MD
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F828-37. PubMed ID: 16332931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-δ activation ameliorates albuminuria by preventing nephrin loss and restoring podocyte integrity in type 2 diabetes.
    Lee EY; Kim GT; Hyun M; Kim S; Seok S; Choi R; Lee MY; Chung CH
    Nephrol Dial Transplant; 2012 Nov; 27(11):4069-79. PubMed ID: 22892126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension.
    Yousif MH; Akhtar S; Walther T; Benter IF
    Cell Biochem Funct; 2008; 26(2):256-63. PubMed ID: 18035860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus.
    Amazonas RB; Lopes de Faria JB
    Life Sci; 2006 Oct; 79(22):2135-43. PubMed ID: 16890245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes.
    Ijaz A; Tejada T; Catanuto P; Xia X; Elliot SJ; Lenz O; Jauregui A; Saenz MO; Molano RD; Pileggi A; Ricordi C; Fornoni A
    Kidney Int; 2009 Feb; 75(4):381-8. PubMed ID: 18971923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.